Patents by Inventor Matthew Walenciak

Matthew Walenciak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6821789
    Abstract: A collection container and method for collecting a predetermined volume of a biological sample, and particularly a whole blood sample, includes at least one gene induction blocking agent in an amount effective to stabilize and inhibit gene induction. The gene induction blocking agent is able to stabilize nucleic acids in the biological sample at the point of collection to block ex vivo gene induction in the sample when stored at room temperature. The stabilizing agents include cationic compounds, detergents, particularly cationic detergents, chaotropic salts, ribonuclease inhibitors, chelating agents, organic solvents, organic reducing reagents, and mixtures thereof. The biological sample is collected directly from the animal and immediately mixed with the gene induction blocking agent without any intermediate processing or handling.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: November 23, 2004
    Assignee: Becton, Dickinson and Company
    Inventors: Frank A. Augello, Lynne Rainen, Matthew Walenciak, Uwe Oelmüller, Ralf Wyrich, Helge Bastian
  • Publication number: 20040162540
    Abstract: The present invention is directed to a fluid transfer device including first and second sampling tube holders for accommodating sampling tubes therein, with the holders joined together through a coupler. The coupler includes a cannula having a first end extending into the first sampling tube holder and a second end extending into the second sampling tube holder, thereby establishing a path for fluid flow between a first sampling tube accommodated within the first holder and a second sampling tube accommodated within the second holder through the cannula. The coupler may be a two piece system including two hubs with separate cannulas extending from each hub, and each hub may be separately joined to the holders prior to joining the hubs to form the coupler. The coupler may further include a connector extending between the two hubs.
    Type: Application
    Filed: February 13, 2003
    Publication date: August 19, 2004
    Applicant: Becton, Dickinson and Company
    Inventors: Matthew Walenciak, Frank Augello, Kirk Swenson
  • Publication number: 20040048384
    Abstract: A collection container and method for collecting a predetermined volume of a biological sample, and particularly a whole blood sample, includes at least one gene induction blocking agent in an amount effective to stabilize and inhibit gene induction. The gene induction blocking agent is able to stabilize nucleic acids in the biological sample at the point of collection to block ex vivo gene induction in the sample when stored at room temperature. The stabilizing agents include cationic compounds, detergents, particularly cationic detergents, chaotropic salts, ribonuclease inhibitors, chelating agents, organic solvents, organic reducing reagents, and mixtures thereof. The biological sample is collected directly from the animal and immediately mixed with the gene induction blocking agent without any intermediate processing or handling.
    Type: Application
    Filed: July 2, 2003
    Publication date: March 11, 2004
    Inventors: Frank A. Augello, Lynne Rainen, Matthew Walenciak, Uwe Oelmuller, Ralf Wyrich, Helge Bastian
  • Publication number: 20040043505
    Abstract: The present invention is directed to a method and device for collecting and stabilizing a biological sample, particularly a whole blood sample. More specifically, the present invention relates to the use of about 5.6 to about 37.5 mM, preferably about 5.6 to about 10.1 mM, EDTA during collection of the sample and to evacuated fluid sample containers having an amount of EDTA contained therein such that, when the sample is collected, the amount achieved is about 5.6 to about 37.5 mM, preferably about 5.6 to about 10.1 mM, EDTA to stabilize the sample.
    Type: Application
    Filed: May 7, 2003
    Publication date: March 4, 2004
    Inventors: Matthew Walenciak, Lynne Rainen, Daniel Groelz, Helge Bastian, Uwe Oelmueller
  • Patent number: 6617170
    Abstract: A collection container and method for collecting a predetermined volume of a biological sample, and particularly a whole blood sample, includes at least one gene induction blocking agent in an amount effective to stabilize and inhibit gene induction. The gene induction blocking agent is able to stabilize nucleic acids in the biological sample at the point of collection to block ex vivo gene induction in the sample when stored at room temperature. The stabilizing agents include cationic compounds, detergents, particularly cationic detergents, chaotropic salts, ribonuclease inhibitors, chelating agents, organic solvents, organic reducing reagents, and mixtures thereof. The biological sample is collected directly from the animal and immediately mixed with the gene induction blocking agent without any intermediate processing or handling.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: September 9, 2003
    Assignees: Becton, Dickinson and Company, Qiagen GmbH
    Inventors: Frank A. Augello, Lynne Rainen, Matthew Walenciak, Uwe Oelmüller, Ralf Wyrich, Helge Bastian
  • Patent number: 6602718
    Abstract: A collection container and method for collecting a predetermined volume of a biological sample, and particularly a whole blood sample, includes an effective amount of at least one stabilizing agent. The stabilizing agent is able to stabilize nucleic acids in the biological sample at the point of collection to prevent enzymatic degradation of the nucleic acids. The stabilizing agents include cationic compounds, detergents, particularly cationic detergents, chaotropic salts, ribonuclease inhibitors, chelating agents, and mixtures thereof.
    Type: Grant
    Filed: November 8, 2000
    Date of Patent: August 5, 2003
    Assignees: Becton, Dickinson and Company, Qiagen GmbH
    Inventors: Frank A. Augello, Lynne Rainen, Matthew Walenciak, Uwe Oelmüller, Ralf Wyrich, Helge Bastian
  • Publication number: 20020146677
    Abstract: A collection container and method for collecting a predetermined volume of a biological sample, and particularly a whole blood sample, includes at least one gene induction blocking agent in an amount effective to stabilize and inhibit gene induction. The gene induction blocking agent is able to stabilize nucleic acids in the biological sample at the point of collection to block ex vivo gene induction in the sample when stored at room temperature. The stabilizing agents include cationic compounds, detergents, particularly cationic detergents, chaotropic salts, ribonuclease inhibitors, chelating agents, organic solvents, organic reducing reagents, and mixtures thereof. The biological sample is collected directly from the animal and immediately mixed with the gene induction blocking agent without any intermediate processing or handling.
    Type: Application
    Filed: October 30, 2001
    Publication date: October 10, 2002
    Applicant: Becton Dickinson and Company and Qiagen GmbH.
    Inventors: Frank A. Augello, Lynne Rainen, Matthew Walenciak, Uwe Oelmuller, Ralf Wyrich, Helge Bastian